BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

NuMedii

NuMedii logo

Founded
2008
Geography
United States of America based
Funding
$5.500 M

NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.

Technologies

AI Companies (Drug Discovery)  


Posts Mentioning This Company

Biopharma Insights
Biopharma Insights

R&D Platform

Discover connections between drugs and diseases at a systems level by analyzing hundreds of millions of raw human, biological, pharmacological, and clinical data points. Allows researchers to: Find drug candidates and biomarkers predictive of efficacy for diseases.


AIDD

Read more

Pipelines

No pipelines published yet

Products

 

Services

No services posted yet